These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29491706)

  • 1. Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity.
    Sahibzada MUK; Sadiq A; Faidah HS; Khurram M; Amin MU; Haseeb A; Kakar M
    Drug Des Devel Ther; 2018; 12():303-312. PubMed ID: 29491706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability.
    Sahibzada MUK; Sadiq A; Khan S; Faidah HS; Naseemullah ; Khurram M; Amin MU; Haseeb A
    Drug Des Devel Ther; 2017; 11():1453-1464. PubMed ID: 28553075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
    Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-Polyvinylpyrrolidone Composites Prepared by Evaporative Precipitation of Nanosuspension for Dissolution Enhancement.
    Kakran M; Sahoo NG; Li L; Judeh Z; Panda P
    J Biomater Sci Polym Ed; 2011; 22(1-3):363-78. PubMed ID: 20566035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension.
    Kakran M; Sahoo NG; Li L; Judeh Z
    J Pharm Pharmacol; 2010 Apr; 62(4):413-21. PubMed ID: 20604829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
    Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
    Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine.
    Shi C; Tong Q; Fang J; Wang C; Wu J; Wang W
    Eur J Pharm Sci; 2015 Jul; 74():11-7. PubMed ID: 25861719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
    Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Characterization, and Evaluation of Physcion Nanoparticles for Enhanced Oral Bioavailability: An Attempt to Improve Its Antioxidant and Anticancer Potential.
    Khuda F; Zahir I; Khalil AAK; Ali S; Ullah N; Albariqi AH; Ahn MJ; Shafique M; Mehtap Büyüker S; Almawash S
    ACS Omega; 2023 Sep; 8(37):33955-33965. PubMed ID: 37744808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity.
    Ahmed S; Govender T; Khan I; Rehman NU; Ali W; Shah SMH; Khan S; Hussain Z; Ullah R; Alsaid MS
    Drug Des Devel Ther; 2018; 12():255-269. PubMed ID: 29440875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension.
    Kakran M; Sahoo NG; Li L; Judeh Z; Wang Y; Chong K; Loh L
    Int J Pharm; 2010 Jan; 383(1-2):285-92. PubMed ID: 19781606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats.
    Zhang G; Zhang J
    Drug Des Devel Ther; 2018; 12():2509-2518. PubMed ID: 30147298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles.
    Mohamed MS; Abdelhafez WA; Zayed G; Samy AM
    AAPS PharmSciTech; 2019 Dec; 21(2):35. PubMed ID: 31879830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
    Zhang J; Huang Y; Liu D; Gao Y; Qian S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.